Clinical Trials Browser

OTHER × Leukemia, Myeloid, Acute × Drug Therapy × Clear all

NCT06177067 2026-03-04

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT06458257 2025-07-29

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07069933 2025-07-17

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06458244 2024-11-07

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02936089 2023-08-08

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

Phase NA Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Phase 1/2 Unknown

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02298166 2021-10-06

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

Phase 3 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02229266 2021-08-16

HINKL

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01872819 2018-07-11

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Phase NA Completed

16 enrolled 9 charts

Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00640796 2014-04-24

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Phase 1 Completed

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00428558 2013-12-20

Timed-Sequential Induction in CBF-AML

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00390715 2010-03-15

Treatment of Acute Myeloblastic Leukemia in Younger Patients

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00931138 2009-07-02

ALFA 9801

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00152139 2009-01-29

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile